Search Results for: hepatitis C virus

September 26, 2014September 26, 2014

Genetic ‘Instruction Set’ For Antibodies Effective Treatment For Hepatitis C In Mice

Hepatitis C, News

A new study led by Princeton University researchers has determined that a “triple-punch” of antibodies both prevented hepatitis C infection and wiped out the disease after it had established itself ... Read more

September 25, 2014September 25, 2014

Gilead Files Fixed-Dose Hepatitis C Combo NDA for Japanese Market

Hepatitis C, News

Gilead Sciences, Inc. recently submitted a New Drug Application (NDA) to the Pharmaceutical and Medical Devices Agency (PMDA) in Japan for approval of an experimental combination therapy of the NS5A inhibitor ledipasvir ... Read more

September 24, 2014September 24, 2014

Scientists Board Space Station to Crystallize Hepatitis C Proteins

News

The World Health Organization has declared Hepatitis C a global health concern, and Egypt is at its epicenter, with nearly 8% of its population diagnosed with a chronic hepatitis C ... Read more

September 23, 2014September 23, 2014

Janssen Heralds NICE Ruling on Hepatitis C Drug Olysio For Patients With Genotype 1, Calls For Further Approval For Genotype 4

Hepatitis C, News

The National Institute of Health and Care Excellence (NICE) recently released the Appraisal Consultation Document (ACD) for the use of Olysio® (simeprevir), developed jointly by Janssen R&D Ireland and Medivir ... Read more

April 27, 2017April 27, 2017

Gilead Sciences Presents New Data on HCV, HBV Treatment with Harvoni

Hepatitis B, Hepatitis C, News

Harvoni (ledipasvir/sofosbuvir) may become a potential treatment for children with chronic hepatitis C virus (HCV) infection and adults with hepatitis B virus (HBV), according to results of two clinical trials ... Read more

March 28, 2017March 28, 2017

European Public Health Alliance Joins Patent Opposition for HCV Treatment

Hepatitis C, News

The European Public Health Alliance (EPHA) is one of 30 civil society organizations from 17 European countries to file a coordinated patent opposition on sofosbuvir with the European Patent Office ... Read more

March 21, 2017March 21, 2017

HCV Gene Mutations Present New Challenges for Vaccine Development

Hepatitis C, News

The hepatitis C virus (HCV) is known to mutate to avoid recognition by antibodies, neutralizing molecules of the host’s immune system. Surprisingly, researchers found that these mutations can occur in ... Read more

February 28, 2017February 28, 2017

Scientists Identify Key Regulator of Immune Responses, Promising More Effective Antiviral Therapies

Hepatitis C, News

Researchers have discovered a key regulator of our cells’ innate immune response against pathogens, including the hepatitis C virus (HCV). Findings from scientists at Sanford Burnham Prebys Medical Discovery Institute ... Read more

February 21, 2017February 21, 2017

‘Treat-All’ Medicaid Policy Improves Outcomes, Reduces Healthcare Costs in HCV

Hepatitis C, News

A restrictive Medicaid policy in many states limits hepatitis C virus (HCV) treatment to patients with severe disease, which leads to suboptimal treatment outcomes, high patient burden, and excessive costs. Now, ... Read more

January 26, 2017January 26, 2017

Marketing Application for HCV Treatment Candidate G/P Validated in Europe

Hepatitis C, News

AbbVie’s marketing authorization application (MAA) for its investigational drug glecaprevir/pibrentasvir (G/P), developed as a treatment for chronic hepatitis C virus (HCV) genotypes 1 to 6, has been validated by the European ... Read more